On October 8, 2014, AstraZeneca AB (NYSE: AZN) terminated its Collaborative Research and License Agreement with Targacept ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE